CHERISH Events

Conference Roundup: #INHSU2024

A curated list of appearances featuring CHERISH researchers and colleagues.

October 8-11, 2024

The 12th International Conference on Health and Hepatitis in Substance Users, Athens, Greece

Established in 2009, the International Network on Health and Hepatitis in Substance Users (INHSU) is a recognized leader in amplifying research and clinical advances in hepatitis C prevention, treatment, and care for people who use drugs.

Entering its 12th year, this conference welcomes a global network of practitioners, researchers, community members, and people who use drugs and remains committed to creating equitable access to treatment and health services to address infectious diseases and drug-related harms.

Connect with our CHERISH researchers and colleagues attending and view the online program here.

Wednesday, October 9th

4:00 p.m. – 5:30 p.m.

Concurrent 2A: Other Infections, 📍 Banqueting Hall

  • Joshua Barocas, Associate Professor of Medicine, University of Colorado School of Medicine, CHERISH Research Affiliate
    • Future therapies for skin and soft tissue infections in people who inject drugs, 4:40 p.m. – 5:00 p.m.

Concurrent 2D: Workshop – Considerations for economic evaluations of harm reduction programs: bridging data and policy, 📍 MC3

  • Sean M. Murphy, Professor, Weill Cornell Medical Center, CHERISH Methodology Core Co-director
    • Designing Economic Evaluations to Inform Harm Reduction Policy, 4:05 p.m.- 4:20 p.m.
  • Czarina Behrends, Assistant Professor, Weill Cornell Medical College, CHERISH Research Affiliate
    • Collaborative Insights: Collaborating with Health Departments in Economic Studies for Evidence-Based Harm Reduction Policies, 4:20 p.m.- 4:35 p.m.
  • Xiao Zang, Assistant Professor, University of Minnesota, CHERISH Research Affiliate
    • Leveraging Decision Analytic Modelling for Robust and Equitable Harm Reduction Policy: A Collaborative Approach, 4:50 p.m.- 5:05 p.m.

Thursday, October 10th

1:45 p.m. – 3:30 p.m.

Concurrent 4B: Scaling HCV Treatment, 📍 Nikos Skalkotas Hall

  • Ane-Kristine Finbråten, Senior Researcher, Unger Vetlesen Institute
    • Implementation of Low Threshold HCV Treatment in New York State, 2:00 p.m.- 2:15 p.m.

4:00 p.m. – 5:30 p.m.

Concurrent 5C: Evaluating the impact of supervised consumption sites across the world: methodological considerations in diverse political and socioeconomic contexts, 📍 MC2

  • Brandon D.L. Marshall, Professor, Brown University School of Public Health, CHERISH Research Affiliate
    • Discussant, 4:50 p.m.- 5:00 p.m.

Friday, October 11th

2:15 p.m. – 3:30 p.m.

Concurrent 7B: HIV and Other Infectious Diseases, 📍 Nikos Skalkotas Hall

  •  Tyler Bartholomew, Assistant Professor, University of Miami, CHERISH Research Affiliate
    • Disparities in HIV and HCV Retesting Rates Among People Who Inject Drugs Accessing a Syringe Services Program in Miami, United States, 3:15 p.m. – 3:20 p.m.

4:00 p.m. – 5:00 p.m.

Plenary 5: Conference Closing, 📍 Banqueting Hall

  • Shashi N. Kapadia, Assistant Professor of Medicine, Weill Cornell Medicine, CHERISH Research Affiliate
    • Clinical Science Rapporteur, 4:30 p.m. – 4:40 p.m.

Posters

  • Tyler Bartholomew, Assistant Professor, University of Miami, CHERISH Research Affiliate
    • (#13) Rapid Initiation Of Antiretrovirals at a Syringe Services Program for People with Hiv Who Inject Drugs
    • (#113) Advancing Equitable Access to HIV/HCV testing among People Who Inject Drugs: A Mixed-Method Study of a Multicomponent Implementation Strategy to Increase Adoption and Implementation of Opt-Out Testing At Syringe Services Programs
  • Czarina Behrends, Assistant Professor, Weill Cornell Medical College, CHERISH Research Affiliate
    • (#151) Organizational Delivery Of Health Services At Syringe Services Programs In The United States: A Qualitative Study
  • Brandon D.L. Marshall, Professor, Brown University School of Public Health, CHERISH Research Affiliate
    • (#208) Evaluating Pervasiveness Of Fentanyl Exposure Among People Who Use Drugs In A U.S. Northeastern State Using Classification And Regression Tree Analysis
    • (#209) Statewide Trends In Medications For Opioid Use Disorder Utilization In Rhode Island, United States, 2017-2023
  • Xiao Zang, Assistant Professor, University of Minnesota, CHERISH Research Affiliate
    • (#249) Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts